Global Iron Sucrose Injection Market Size, Share, and COVID-19 Impact Analysis, Russia-Ukraine War Impact, Tariff Analysis, By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Chemotherapy-Induced Anemia, and Others), By End-user (Hospitals, Out-patient Infusion & Oncology Centers, Dialysis Centers, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Iron Sucrose Injection Market Insights Forecasts To 2035

• The Global Iron Sucrose Injection Market Size Was Estimated at USD 2.65 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.14% from 2025 to 2035
• The Worldwide Iron Sucrose Injection Market Size is Expected to Reach USD 5.66 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, The Global Iron Sucrose Injection Market size was worth around USD 2.65 Billion in 2024 and is Projected To Grow from USD 2.84 Billion in 2025 to around USD 5.66 Billion by 2035 with a compound annual growth rate (CAGR) of 7.14 % from 2025 to 2035. The growing prevalence of anemia is considered a persistent public health challenge, requiring effective and rapid treatment. Intravenous iron therapy is essentially needed as a treatment option where oral iron supplements are insufficient or poorly tolerated. It is anticipated that the increasing prevalence of iron deficient anemia, surging need for effective intravenous iron treatments, and improvement in healthcare infrastructure, worldwide, will support market growth.

Global Iron Sucrose Injection Market Forecast and Revenue Outlook

• 2024 Market Size: USD 2.65 Billion
• 2035 Projected Market Size: USD 5.66 Billion
• CAGR (2025-2035): 7.14%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Market Overview

The iron sucrose injection market refers to the industry focusing on the production, distribution, and sale of iron sucrose, an intravenous iron replacement product used for treating iron deficiency anemia (IDA), especially in patients with chronic kidney disease. Iron sucrose has trade name Venofer. Iron sucrose injection is an iron replacement product used for treating iron deficiency anemia, which can be caused by chronic kidney disease and is to be given only by or under the direct supervision of a doctor. There are increasing advancements in drug delivery technologies like nanoparticle-based formulations for improving iron absorption with reduced side effects.

The global market share is anticipated to be supported by expanding R&D efforts by major industry participants, including Daiichi Sankyo, Alembic Pharmaceuticals, Fresenius Kabi, Vifor Pharma, Sanofi, and others, for improving drug efficacy, safety, and production efficiency. There are opportunities in the developing market due to the increasing adoption of personalised medicine, which encourages manufacturers to develop targeted and effective drug formulations. Furthermore, the combination therapies of iron sucrose injection for managing complex anemia cases are opening up new opportunities in the development of iron products.

Key Market Insights

• North America is expected to account for the largest share in the Iron sucrose injection market during the forecast period.
• In terms of application, the chronic kidney diseases segment is projected to lead the iron sucrose injection market with the largest share throughout the forecast period
• In terms of end-user, the hospitals segment captured the largest portion of the market

Iron Sucrose Injection Market Trends

• Increasing emphasis on developing generic drugs
• R&D efforts in developing formulations with the growing emphasis on patient safety and minimising side effects
• Development of biodegradable infusion systems and minimal waste disposal solutions

Report Coverage

This research report categorizes the iron sucrose injection market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the Iron Sucrose Injection Market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the iron sucrose injection market.

Driving factors

The growing prevalence of iron deficient anemia is driving the demand for iron sucrose injection for replenishing a patient’s iron stores, which are essential for producing red blood cells and haemoglobin. It was found that iron deficiency anemia is the leading cause of anemia, affecting over 1.27 billion people. The growing demand for effective intravenous iron treatment due to its effectiveness in elevating haemoglobin level with the minimum risk that may cause due to unnecessary blood transfusion, is propelling the market.

Restraining Factor

One of the main factors restraining the iron sucrose injection market is the strict regulatory standards and competition with alternative oral formulations. Further, potential adverse effects associated with IV iron sucrose injection, including low blood pressure and allergic reactions, hamper its adoption, ultimately impacting the market growth.

Market Segmentation 

The global iron sucrose injection market is divided into application and end-user.

Global Iron Sucrose Injection Market, By Application:

Which segment dominates the iron sucrose injection market in terms of application, and what factors are driving the market?

The chronic kidney diseases segment dominated the market with the largest share, due to an increasing incidence of chronic kidney disease driven by factors like diabetes and hypertension. Iron deficiency anemia is commonly associated with chronic diseases, including chronic kidney disease, where erythropoietin production is decreased.  

The inflammatory bowel disease segment is anticipated to grow at a significant CAGR during the forecast period, driven by the increasing prevalence of IBD, along with upsurging awareness about anemia management. IBD-associated anemia is successfully treated with IV-administered iron sucrose to provide enough iron to the body.

Global Iron Sucrose Injection Market, By End-user:

What are the factors responsible for the dominance of hospitals segment in the iron sucrose injection market?

The hospitals segment dominated the iron sucrose injection market during the forecast period. This is attributed to the increasing number of hospital admissions and prevalence of anaemia-related disorders. In hospitals, iron sucrose injection is used for the rapid treatment of iron deficiency anemia by replenishing the body’s iron stores, especially when oral iron is ineffective or not tolerated.  

The dialysis centers segment is anticipated to grow at a significant CAGR during the forecast period, due to the increasing prevalence of CKD, especially in end-stage renal disease (ESRD). IV iron replacement therapy is required in hemodialysis patients and is continuously integrated into routine sessions.

Regional Segment Analysis of the Global Iron Sucrose Injection Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Which region is holding the largest share in the global iron sucrose injection market, and what factors are driving the market?

North America is expected to hold the largest share of the global iron sucrose injection market over the forecast period. The North American region's supremacy includes the increasing approvals and launch of new IV drugs. Further, the number of benefits provided by intravenous iron drugs, such as quicker and more effective iron replenishment, is propelling the market. Favourable regulatory policies for approval of new generic versions, along with an ongoing expansion of affordable genetic options, are supporting the market growth.

Why is the U.S. holding the largest share in the North America iron sucrose injection market?

U.S. is anticipated to hold the largest share in the North America iron sucrose injection market, due to the increasing demand for effective anemia management. Further, an increasing focus on improving access to safe and affordable anemia treatment, encouraging innovative solutions with minimal environmental impact, is escalating the market growth.

What factors are contributing to the Asia Pacific region’s rapid growth in the iron sucrose injection market?

Asia Pacific is expected to grow at the fastest CAGR in the Iron Sucrose Injection Market during the forecast period. In the Asia Pacific market, the growing prevalence of chronic diseases like CKD, IBD, and cancer is responsible for driving the iron sucrose injection market demand. Additionally, the high healthcare expenditure and government support for enabling treatment accessibility are contributing to driving the market growth.

Why is China emerging as the leading country in the Asia Pacific iron sucrose injection market?

China is leading the Asia Pacific iron sucrose injection market, driven by the increasing prevalence of anaemia-related disorders and adoption of IV iron therapies. Further, an increasing number of approvals of newer formulations is supporting the market growth of iron sucrose injection.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global iron sucrose injection market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Worldwide Top Key Players In The Iron Sucrose Injection Market Include

• Daiichi Sankyo
• Alkem Laboratories
• Alembic Pharmaceuticals Ltd.
• Emcure Pharma
• Pfizer Inc.
• Sanofi S.A.
• Fresenius Medical Care AG & Co. KGaA
• American Regent, Inc.
• Vifor Pharma Group
• Pharmacosmos A/S
• Sandoz International GmbH
• Teva Pharmaceutical Industries Ltd.
• Watson Pharmaceuticals, Inc.
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent development

• In September 2025, Sandoz, the global leader in affordable medicines, announced the US launch of its generic iron sucrose injection following recent approval by the USFDA.
• In August 2025, Viatris Inc., a global healthcare company, announced the USFDA had approved iron sucrose injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia (IDA) in adult and pediatric patients with chronic kidney disease (CKD).

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Iron Sucrose Injection Market based on the following segments:

Global Iron Sucrose Injection Market, By Application

• Chronic Kidney Disease
• Inflammatory Bowel Disease
• Chemotherapy-Induced Anemia
• Others

Global Iron Sucrose Injection Market, By End-user

• Hospitals
• Out-patient Infusion & Oncology Centers
• Dialysis Centers
• Others

Global Iron Sucrose Injection Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa